Biology of Bone Sarcomas and New Therapeutic Developments, Calcif Tissue Int, vol.102, pp.174-195, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01653600
Cells of origin in osteosarcoma: mesenchymal stem cells or osteoblast committed cells, Bone, vol.62, pp.56-63, 2014. ,
Osteosarcoma development and stem cell differentiation, Clin Orthop Relat Res, vol.466, pp.2114-2144, 2008. ,
Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2, J Pathol, vol.219, pp.294-305, 2009. ,
Mesenchymal stroma: Role in osteosarcoma progression, Cancer Lett, vol.405, pp.90-99, 2017. ,
Bone microenvironment signals in osteosarcoma development, Cell Mol Life Sci, vol.72, pp.3097-113, 2015. ,
The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma, Cell Immunol ,
URL : https://hal.archives-ouvertes.fr/inserm-01644725
Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma, Oncotarget, vol.7, pp.78343-78354, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01466103
Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma, BMC Cancer, vol.5, p.123, 2005. ,
Drugs in early clinical development for the treatment of osteosarcoma, Expert Opin Investig Drugs, vol.25, pp.1265-1280, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01466096
Cancer stem cells in osteosarcoma, Cancer Lett, vol.386, pp.189-195, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01466078
Cancer stem cells (CSCs) in cancer progression and therapy, J Cell Physiol ,
Whole exome sequencing of a single osteosarcoma case--integrative analysis with whole transcriptome RNA-seq data, Hum Genomics, vol.8, p.20, 2014. ,
Epigenetic regulation of CXCL12 plays a critical role in mediating tumor progression and the immune response in osteosarcoma, Cancer Res, vol.78, pp.3938-3953, 2018. ,
The stem cell division theory of cancer, Crit Rev Oncol Hematol, vol.123, pp.95-113, 2018. ,
Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas, British J Cancer, vol.101, pp.1425-1432, 2009. ,
Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells, Cancer Sci, vol.102, pp.1774-81, 2011. ,
Lung metastasis 21 years after initial diagnosis of osteosarcoma: a case report, J Med Case Rep, vol.3, p.9298, 2009. ,
Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence, PLoS One, vol.5, p.10999, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00667931
Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas, Oncogene, vol.31, pp.2270-2282, 2012. ,
Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells, Nature Commun, vol.6, p.6411, 2015. ,
Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance, Oncol Rep, vol.24, pp.501-5015, 2010. ,
ALDH activity correlates with metastatic potential in primary sarcomas of bone, J Cancer Ther, vol.5, pp.331-338, 2014. ,
Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity, J Cancer, vol.128, pp.294-303, 2011. ,
Comparison of cancer stem cell antigen expression by tumor cell lines and by tumor biopsies from dogs with melanoma and osteosarcoma, Vet Immunol Immunopathol, vol.161, pp.132-140, 2014. ,
, , p.133, 2015.
, CD44(+) Cells Mediate in the Lung Metastasis of Osteosarcoma, J Cell Biochem, vol.116, pp.1719-1729
CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance, Cancer Res, vol.70, pp.4602-4612, 2010. ,
Detection and characterization of CD133+ cancer stem cells in human solid tumours, PloS one, vol.3, p.3469, 2008. ,
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo, FASEB J, vol.25, pp.2022-2030, 2011. ,
CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study, Exp Ther Med, vol.4, pp.435-441, 2012. ,
CD133 expression in osteosarcoma and derivation of CD133+ cells, Mol Med Rep, vol.7, pp.577-584, 2013. ,
Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells, Stem Cells, vol.32, pp.959-973, 2014. ,
The role of CD133 in cancer: a concise review, Clin Transl Med, vol.7, p.18, 2018. ,
CD271+ osteosarcoma cells display stem-like properties, PloS one, vol.9, p.98549, 2014. ,
Defective autophagy leads to the suppression of stem-like features of CD271+ osteosarcoma cells, J Biomed Sci, vol.23, p.82, 2016. ,
Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma, PLoS One, vol.7, p.41401, 2012. ,
Hu FW (2107) DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells, Oncol Lett, vol.14, pp.171-179 ,
KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells, Acta Pharmacol ,
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells, Stem Cell Reports, vol.8, pp.1617-1629, 2017. ,
Osteosarcoma stem cells have active Wnt/beta-catenin and overexpress SOX2 and KLF4, J Cell Physiol, vol.231, pp.876-886, 2016. ,
Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling, Eur Rev Med Pharmacol Sci, vol.21, pp.4516-4528, 2017. ,
Prominent role of RAB39A-RXRB axis in cancer development and stemness, Oncotarget, vol.9, pp.9852-9866 ,
Overexpression of TBL1XR1 confers tumorigenic capability and promotes recurrence of osteosarcoma, Eur J Pharmacol in press ,
Overexpression of SENP1 reduces the stemness capacity of osteosarcoma stem cells and increases their sensitivity to HSVtk/GCV, Int J Oncol, vol.53, pp.2010-2020, 2018. ,
Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity, Oncotarget, vol.4, pp.2326-2364, 2013. ,
MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1, Oncogene, vol.36, pp.231-241, 2017. ,
LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling, Biochem Biophys Res Commun, vol.507, pp.260-266, 2018. ,
2017) miR-34a is downregulated in human osteosarcoma stem-like cells and promotes invasion, tumorigenic ability and self-renewal capacity, Mol Med Rep, vol.15, pp.1631-1637 ,
MiR-19a regulates the cell growth and apoptosis of osteosarcoma stem cells by targeting PTEN, Tumour Biol, vol.39, p.1010428317705341, 2017. ,
negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1, Cancer Cell Int, vol.17, p.29, 2017. ,
Let-7d miRNA shows both antioncogenic and oncogenic functions in osteosarcoma-derived 3AB-OS cancer stem cells, J Cell Physiol, vol.231, pp.1832-1841, 2016. ,
HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy, J Exp Clin Cancer Res, vol.37, p.296, 2018. ,
Stem-like cells in bone sarcomas: implications for tumorigenesis, Neoplasia, vol.7, pp.967-976, 2005. ,
Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines, Int J Oncol, vol.34, pp.1381-1386, 2009. ,
Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line, BMC Cancer, vol.12, p.139, 2012. ,
Analysis of gap junctional intercellular communications using a dielectrophoresis-based microchip, Eur J Cell Biol, vol.96, pp.110-118, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01466071
Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-?B activation, Int J Cancer, vol.140, pp.1331-1345, 2017. ,
Mesenchymal stroma: role in osteosarcoma progression, Cancer Lett, vol.405, pp.90-99, 2017. ,
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression, Clin Cancer Res, vol.23, pp.3721-3733, 2017. ,
, , 2013.
, Transforming growth factor beta1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma, Stem Cells, vol.31, pp.433-479
TGF-? Signaling in bone remodeling and osteosarcoma progression, J Clin Med, vol.5, issue.11, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01701177
Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/beta-catenin signaling, Cancer Lett, vol.370, pp.286-95, 2016. ,
Crosstalk between peroxisome proliferator-activated receptor gamma and the canonical WNT/?-catenin pathway in chronic Inflammation and oxidative stress during carcinogenesis, Front Immunol, vol.9, p.745, 2018. ,
Immuno-Oncology Integrative Networks: Elucidating the Influences of Osteosarcoma Phenotypes, Cancer Inform, vol.16, p.1176935117721691, 2017. ,
Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma, Oncotarget, vol.7, pp.78343-78354, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01466103
Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma, BMC Cancer, vol.5, p.123, 2005. ,
Osteosarcoma: Accelerating Progress Makes for a Hopeful Future, Front Oncol, vol.8, p.4, 2018. ,
Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance, Biochim Biophys Acta Mol ,
Inhibition of cancer stem cells promoted by Pimozide, Clin Exp Pharmacol Physiol ,
Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition, PLoS One, vol.13, 2018. ,
Single-walled carbon nanotube: One specific inhibitor of cancer stem cells in osteosarcoma upon downregulation of the TGF?1 signaling, Biomaterials, vol.149, pp.29-40, 2017. ,
IWR-1, a tankyrase inhibitor, attenuates Wnt/?-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft, 2018. ,
Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling, Eur Rev Med Pharmacol Sci, vol.21, issue.20, pp.4516-4528, 2017. ,
Metformin increases sensitivity of osteosarcoma stem cells to cisplatin by inhibiting expression of PKM2, Int J Oncol, vol.50, pp.1848-1856, 2017. ,
Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells, Cancer Chemother Pharmacol, vol.81, pp.49-63, 2018. ,
Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipidpolymer nanoparticles to both osteosarcoma cells and cancer stem cells, Nanomedicine, vol.14, pp.2115-2127, 2018. ,
Melatonin inhibits osteosarcoma stem cells by suppressing SOX9-mediated signaling, Life Sci, vol.207, pp.253-264, 2018. ,
TSSC3 represses self-renewal of osteosarcoma stem cells and Nanog expression by inhibiting the Src/Akt pathway, Oncotarget, vol.8, pp.85628-85641, 2017. ,
Adaptive fibrogenic reprogramming of osteosarcoma stem cells promotes metastatic growth, Cell Rep, vol.24, pp.1266-1277, 2018. ,
Cytokine induced killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy, Oncoimmunology, vol.7, p.1465161, 2018. ,
, Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259 T Cells in Synovial Sarcoma. Cancer Discov, vol.8, pp.944-957, 2018.